Drug Patent Expirations for Oct 26, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

OMNARIS (ciclesonide)
Astrazeneca Pharms
Patent number:5,482,934
Expiration Date:Oct 24, 2017

ZETONNA (ciclesonide)
Astrazeneca Pharms
Patent number:5,482,934
Expiration Date:Oct 24, 2017

ALVESCO (ciclesonide)
Astrazeneca Pharms
Patent number:5,482,934
Expiration Date:Oct 24, 2017

REMODULIN (treprostinil)
United Therap
Patent number:6,765,117
Expiration Date:Oct 24, 2017

TYVASO (treprostinil)
United Therap
Patent number:6,765,117
Expiration Date:Oct 24, 2017

ORENITRAM (treprostinil diolamine)
United Therap
Patent number:6,765,117
Expiration Date:Oct 24, 2017

NEURONTIN (gabapentin)
Parke Davis
Patent number:6,054,482
Expiration Date:Oct 25, 2017

NEURONTIN (gabapentin)
Pfizer Pharms
Patent number:6,054,482
Expiration Date:Oct 25, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


Leave a Reply

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: